NLS Pharmaceutics ( ($NLSP) ) just unveiled an announcement. On February 25, 2025, NLS Pharmaceutics, in collaboration with ...
Diabetes mellitus type 1 (DM1) is associated with lower probability of incident cardiovascular events than type 2 (DM2), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback